MedTrace Logo

Clarifying the Optimal Application of SLT Therapy Trial

NCT04967989 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 790

Last updated 2025-10-02

No results posted yet for this study

Summary

The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear off before repeating it.

Conditions

  • Glaucoma and Ocular Hypertension

Interventions

PROCEDURE

Low Energy SLT

SLT performed at low energy

PROCEDURE

Standard Energy SLT

SLT performed at standard energy

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • West Virginia University

    collaborator OTHER

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Tony Realini, MD, MPH · West Virginia University

  • Goundappa K Balasubramani, PhD · University of Pittsburgh

  • Stephen Wisniewski, PhD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-07
Primary Completion
2027-06-30
Completion
2027-08-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04967989 on ClinicalTrials.gov